Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News

Pledge the Gift of Life

Each year, the lives of thousands of people across the country are saved because someone made the choice to become an organ donor. In April, Allegheny Health Network is honored to celebrate National Donate Life Month and pay tribute to all of those who have bestowed the precious gift of life to another through organ donation. Visit AHNdonate.org to learn more and register to be an organ donor.

YouTube

SEARCH NEWS

Format: 04/17/2014
Format: 04/17/2014

News

David S. Parda, MD, FACP, Named Chair of National Cancer Institute Review Board

Friday, January 28th, 2011

David S. Parda, M.D., FACP, System Chair of Radiation Oncology at West Penn Allegheny Health System (WPAHS), has been appointed Chair of the National Cancer Institute Adult Central Institutional Review Board (NCI CIRB),effective immediately.

Dr. Parda is the first radiation oncologist to serve as Chair or Vice Chair of this board, which oversees human research protection for cancer clinical trials worldwide.

Dr. Parda will serve a 2-year term as Chair. He previously served as Vice Chair in 2009 and 2010 and as a member from 2006-2008.

At WPAHS, Dr. Parda also serves as System Chair of the Institutional Review Board, overseeing nearly 800 clinical studies involving human subjects throughout hospital and outpatient sites, and is clinical leader of the Oncology Service Line for Allegheny General Hospital (AGH) and WPAHS.

The NCI CIRB initiative began in 2001 and aims to continue a high level of protection for human research participants while reducing administrative burden on local IRB’s and local investigators.

The NCI CIRB is sponsored by the National Cancer Institute in consultation with the Office for Human Research Protections which provides leadership in the protection of the rights, welfare and well-being of subjects involved in research conducted or supported by the US Department of Health and Human Services.

The Adult NCI CIRB oversees all Phase 3 cancer trials from the nine adult cancer cooperative clinical trial groups which include: American College of Surgeons Oncology Group, Cancer and Leukemia Group B, Eastern Cooperative Oncology Group, Gynecologic Oncology Group, North Central Cancer Treatment Group, National Cancer Institute of Canada, National Surgical Adjuvant Breast and Bowel Project, which is based at AGH, Radiation Therapy Oncology Group and Southwest Oncology Group.

The Cancer Cooperative Clinical Trial Program is part of the NCI Cancer Therapy Evaluation Program (CTEP) which coordinates the largest publicly funded oncology clinical trials organization in the world spanning Phase 1-3 trials in all cancers and treatment modalities (surgery, radiation therapy, chemotherapy, biologic therapy).

CTEP oversees 900 active cancer clinical trials which enroll 30,000 study participants annually. 28,000 of these study participants are enrolled annually into the Phase 3 clinical trials from the 9 adult cancer cooperative clinical trials groups and NCI CIRB oversees human research protection for all of these studies.

A facilitated review process has been developed by NCI CIRB which streamlines local IRB reviews of adult national multi-center cancer treatment trials improving the availability of new cancer treatments for all patients. WPAHS has also implemented this facilitated review process which has expedited the availability of advancing care for patients throughout its hospital and outpatient treatment sites.

CTEP trials involve more than 400 grants and cooperative agreements and more than 100 investigational new drugs (INDs).

 

X
West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)











Did you find what you were looking for?


Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 6 + 9 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.